Isodeoxycholic Acid

CAS No. 566-17-6

Isodeoxycholic Acid( —— )

Catalog No. M34864 CAS No. 566-17-6

Isodeoxycholic Acid is a bile acid that is formed via epimerization of deoxycholic acid by intestinal bacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 187 In Stock
10MG 306 In Stock
25MG 591 In Stock
50MG 817 In Stock
100MG 1097 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Isodeoxycholic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Isodeoxycholic Acid is a bile acid that is formed via epimerization of deoxycholic acid by intestinal bacteria.
  • Description
    Isodeoxycholic acid (7α,12α-Dihydroxycholanoic acid) is the 3β-epimer of ursodeoxycholic acid. Isodeoxycholic acid has the effect on choleresis and liver biochemistry.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial | Chloride channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    566-17-6
  • Formula Weight
    392.57
  • Molecular Formula
    C24H40O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (254.73 mM; Ultrasonic )
  • SMILES
    C[C@@]12[C@@]3([C@]([C@]4([C@](C)([C@@H](O)C3)[C@@]([C@@H](CCC(O)=O)C)(CC4)[H])[H])([C@H](O)C[C@@]1(CCCC2)[H])[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Marschall HU, et al. Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis. J Lipid Res. 2001 May;42(5):735-42.?
molnova catalog
related products
  • 5-Hydroxysophoranone

    5-Hydroxysophoranone is extracted from Erythrina subumbrans stems and exhibits high antiplasmodial activity against Plasmodium falciparum (IC50 = 2.5 μg/mL).

  • Praeruptorin A

    Praeruptorin A has the potential to inhibit migration/fusion of preosteoclasts in vitro and bone erosion in vivo by targeting calmodulin and inhibiting the Ca(2+)/calmodulin-CaMKIV-CREB-NFATc1 and/or Ca(2+)/calmodulin-calcineurin-NFATc1 signaling axis.

  • Pivmecillinam hydroc...

    Pivmecillinam hydrochloride is an orally active prodrug of mecillinam an extended-spectrum penicillin antibioticand?is active against gram-negative organisms and used as for amdinocillin.